ROYAL BANK OF CANADA - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 1 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,000
+20.0%
19,479
+60.3%
0.00%
Q2 2023$30,000
+2900.0%
12,148
+1846.8%
0.00%
Q1 2023$1,000
-90.9%
624
-75.9%
0.00%
Q4 2022$11,000
+175.0%
2,593
+60.1%
0.00%
Q1 2022$4,000
-73.3%
1,620
-72.3%
0.00%
Q4 2021$15,000
-11.8%
5,846
+76.6%
0.00%
Q3 2021$17,000
+54.5%
3,310
+115.1%
0.00%
Q2 2021$11,0001,539
+7228.6%
0.00%
Q1 2021$0210.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders